203 related articles for article (PubMed ID: 16166046)
41. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
Iwamoto J
Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
[TBL] [Abstract][Full Text] [Related]
42. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
[TBL] [Abstract][Full Text] [Related]
43. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.
Noguera A; Ros JB; Pavía C; Alcover E; Valls C; Villaronga M; González E
J Pediatr Endocrinol Metab; 2003; 16(4):529-36. PubMed ID: 12793604
[TBL] [Abstract][Full Text] [Related]
44. Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.
Vallo A; Rodriguez-Leyva F; Rodríguez Soriano J
Acta Paediatr; 2006 Mar; 95(3):332-9. PubMed ID: 16497645
[TBL] [Abstract][Full Text] [Related]
45. Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures.
Ohtori S; Akazawa T; Murata Y; Kinoshita T; Yamashita M; Nakagawa K; Inoue G; Nakamura J; Orita S; Ochiai N; Kishida S; Takaso M; Eguchi Y; Yamauchi K; Suzuki M; Aoki Y; Takahashi K
J Clin Neurosci; 2010 Feb; 17(2):209-13. PubMed ID: 20044258
[TBL] [Abstract][Full Text] [Related]
46. [Alendronate for treatment of osteoporoses].
Harada A
Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114
[TBL] [Abstract][Full Text] [Related]
47. Idiopathic juvenile osteoporosis.
Marhaug G
Scand J Rheumatol; 1993; 22(1):45-7. PubMed ID: 8434248
[TBL] [Abstract][Full Text] [Related]
48. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
Soen S
Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
[TBL] [Abstract][Full Text] [Related]
49. Osteoporosis: how long should we treat?
Sebba A
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):502-7. PubMed ID: 18971678
[TBL] [Abstract][Full Text] [Related]
50. [Febril back pain. Vertebral collapse induced by acute leukaemia in a child].
Hbibi M; Atmani S; Abourazzak S; Kamaoui I; Chaouki S; Bouharrou A; Hida M
Arch Pediatr; 2011 May; 18(5):577-8, 597-9. PubMed ID: 21353771
[No Abstract] [Full Text] [Related]
51. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis.
Tu CW; Huang KF; Hsu HT; Li HY; Yang SS; Chen YC
J Surg Res; 2014 Nov; 192(1):112-6. PubMed ID: 24948545
[TBL] [Abstract][Full Text] [Related]
52. Treatment of repeated and multiple new-onset osteoporotic vertebral compression fractures with teriparatide.
Tu PH; Liu ZH; Lee ST; Chen JF
J Clin Neurosci; 2012 Apr; 19(4):532-5. PubMed ID: 22341147
[TBL] [Abstract][Full Text] [Related]
53. Short-term efficacy of monthly pamidronate infusion in patients with osteogenesis imperfecta.
Choi JH; Shin YL; Yoo HW
J Korean Med Sci; 2007 Apr; 22(2):209-12. PubMed ID: 17449925
[TBL] [Abstract][Full Text] [Related]
54. [Sacroplasty for the treatment of insufficiency fractures of the sacrum].
Hess GM
Orthopade; 2006 Aug; 35(8):865-70. PubMed ID: 16804730
[TBL] [Abstract][Full Text] [Related]
55. What is your diagnosis? Generalized loss of cortical bone density and a displaced compression fracture of 10th thoracic vertebra.
Cook JL; Gross MM
J Am Vet Med Assoc; 1996 Apr; 208(7):1019-20. PubMed ID: 8621309
[No Abstract] [Full Text] [Related]
56. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.
Laroche M; Livideanu C; Paul C; Cantagrel A
Am J Med; 2011 Aug; 124(8):776-8. PubMed ID: 21787907
[TBL] [Abstract][Full Text] [Related]
57. Intravenous zoledronic Acid given every 6 months in childhood osteoporosis.
Ooi HL; Briody J; Biggin A; Cowell CT; Munns CF
Horm Res Paediatr; 2013; 80(3):179-84. PubMed ID: 24052046
[TBL] [Abstract][Full Text] [Related]
58. Impairments precede fractures.
Schute LL
Dtsch Arztebl Int; 2009 Jan; 106(3):38; author reply 39-40. PubMed ID: 19564963
[No Abstract] [Full Text] [Related]
59. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
Aström E; Magnusson P; Eksborg S; Söderhäll S
Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
[TBL] [Abstract][Full Text] [Related]
60. The Spectrum of Recovery From Fracture-Induced Vertebral Deformity in Pediatric Leukemia.
Dal Osto LC; Konji VN; Halton J; Matzinger MA; Bassal M; Rauch F; Ward LM
Pediatr Blood Cancer; 2016 Jun; 63(6):1107-10. PubMed ID: 26878592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
